Quantum BioPharma (QNTM)

Profile

Full Name

Quantum BioPharma Ltd.

Ticker Symbol

QNTM

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

IPO

Indexes

Not included

Website

http://www.quantumbiopharma.com

Employees

-

Key Details

Price

$6.94(+3.74%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$13.12(+56.16% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.94
QNTM price is $6.94

30-Day Relative Volume

0.07
QNTM 30-day relative volume is 0.07

Price Performance

Price Most recent change

+3.74%
QNTM price was up +3.74% on Apr 11, 2025

Price YTD change

+88.59%
QNTM price is up +88.59% since January 1st

Price 1-year change

-82.67%
QNTM price is down -82.67% year-on-year

Price 3-year change

-88.64%
QNTM price is down -88.64% over the past 3 years

Price Range

Price All-time high

$11431.88
QNTM price is currently -99.94% below its historical high of $11431.88

Price 3-year low

$2.70
QNTM price is currently +157.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$15.96M
QNTM market capitalization is $15.96 million

Market cap 3-year change

-55.9%
QNTM market capitalization is down -55.9% over the past 3 years

Market cap All-time high

$917.10M
QNTM market capitalization is currently -98.26% below its historical high of $917.10 million

Market cap sector rank

25.55%
QNTM market capitalization is higher than 25.55% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+269.69%
QNTM shares outstanding is up +269.69% year-on-year

Shares Outstanding 3-Year Change

+288.3%
QNTM shares outstanding is up +288.3% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.91
QNTM beta is 1.91

200-day SMA

$5.71
QNTM price is currently +21.46% above its 200-day simple moving average

50-day SMA

$6.88
QNTM price is currently +0.87% above its 50-day simple moving average

RSI

51.78
QNTM 14-day relative strength index is 51.78

Volume

0.07
QNTM 30-day relative volume is 0.07

ATR

$1.10
QNTM average true range is $1.10

10-day Historical Volatility

131.53%
QNTM 10-day historical volatility is 131.53%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
QNTM annual revenue value is unknown

Revenue Analysts estimate

$8.68M
QNTM annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
QNTM annual revenue 1-year change is unknown

Revenue Sector rank

-
QNTM annual revenue is unknown

EPS

EPS

-$13.12
QNTM annual earnings per share is -$13.12

EPS Analysts estimate

-
QNTM annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+56.16%
QNTM annual earnings per share is up +56.16% year-on-year

EPS Sector rank

9.83%
QNTM annual earnings per share is higher than 9.83% of companies in Healthcare sector

Profit

Gross profit

-
QNTM annual gross profit value is unknown

Gross margin

-
QNTM annual gross profit margin value is unknown

Operating profit

-$15.88M
QNTM annual operating income is -$15.88 million

Operating margin

-
QNTM annual operating profit margin value is unknown

Net income

-$14.20M
QNTM annual net profit is -$14.20 million

Net margin

-
QNTM annual net profit margin value is unknown

Expenses

Total expenses

$15.88M
QNTM annual total expenses is $15.88 million

Operating expenses

$15.88M
QNTM annual total operating expenses is $15.88 million

Cost of goods sold

-
QNTM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$9.31M
QNTM annual SGA is $9.31 million

Depreciation and amortization

$490.60K
QNTM annual depreciation & amortization is $490.60 thousand

Interest expense

$47.60K
QNTM annual interest expense is $47.60 thousand

Income tax

-
QNTM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$14.87M
QNTM annual earnings before interest & taxes is -$14.87 million

EBITDA

-$14.38M
QNTM annual EBITDA is -$14.38 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.12M
QNTM annual total assets is $17.12 million

Non current assets

$5.07M
QNTM annual long term assets is $5.07 million

Current assets

$12.05M
QNTM annual total current assets is $12.05 million

Cash and cash equivalents

$6.00M
QNTM annual cash & cash equivalents is $6.00 million

Accounts receivable

-
QNTM annual accounts receivable value is unknown

Inventory

$117.20K
QNTM annual inventory is $117.20 thousand

Liabilities

Total liabilities

$6.68M
QNTM annual total liabilities is $6.68 million

Long term liabilities

$0.00
QNTM annual total long term liabilities is $0.00

Current liabilities

$6.68M
QNTM annual total current liabilities is $6.68 million

Accounts payable

$3.25M
QNTM annual accounts payable is $3.25 million

Debt

Total debt

$824.90K
QNTM annual total debt is $824.90 thousand

Total debt 1-year change

+143.19%
QNTM annual total debt is up +143.19% year-on-year

Long term debt

-
QNTM annual long term debt value is unknown

Short term debt

$824.90K
QNTM annual short term debt is $824.90 thousand

Equity & Capital

Shareholders equity

$11.48M
QNTM annual stockholders equity is $11.48 million

Book value

$11.48M
QNTM annual book value is $11.48 million

Retained earnings

-$172.11M
QNTM annual retained earnings is -$172.11 million

Working capital

$5.37M
QNTM annual working capital is $5.37 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.88M
QNTM annual cash flow from operations is -$6.88 million

Cash from operations 1-year change

+36.49%
QNTM annual cash flow from operations is up +36.49% year-on-year

Cash from investing

-$1.50M
QNTM annual cash flow from investing activities is -$1.50 million

Cash from investing 1-year change

-457.72%
QNTM annual cash flow from investing activities is down -457.72% year-on-year

Cash from financing

$11.62M
QNTM annual cash flow from financing activities is $11.62 million

Cash from financing 1-year change

+471.61%
QNTM annual cash flow from financing activities is up +471.61% year-on-year

CAPEX

CAPEX

-
QNTM annual capital expenditures value is unknown

CAPEX 1-year change

-
QNTM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$6.88M
QNTM annual free cash flow is -$6.88 million

Free cash flow 1-year change

+36.49%
QNTM annual free cash flow is up +36.49% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
QNTM annual gross profit margin value is unknown

Operating margin

-
QNTM annual operating profit margin value is unknown

Net margin

-
QNTM annual net profit margin value is unknown

ROA & ROE

ROA

-82.96%
QNTM annual return on assets is -82.96%

ROE

-123.71%
QNTM annual return on equity is -123.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
QNTM price to earnings ratio value is unknown

PE ratio Sector rank

-
QNTM price to earnings ratio is unknown

PB Ratio

PB ratio

1.39
QNTM price to book ratio is 1.39

PB ratio Sector rank

53.04%
QNTM price to book ratio is higher than 53.04% of companies in Healthcare sector

PS Ratio

PS ratio

-
QNTM price to sales ratio value is unknown

PS ratio Sector rank

-
QNTM price to sales ratio is unknown

Enterprise value

Enterprise value

$10.79M
QNTM enterprise value is $10.79 million

Enterprise value Sector rank

25.85%
QNTM enterprise value is higher than 25.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.75
QNTM EV/EBITDA is -0.75

EV/EBITDA Sector rank

46.92%
QNTM EV/EBITDA is higher than 46.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.80
QNTM annual current ratio is 1.80

Quick ratio

1.79
QNTM annual quick ratio is 1.79

Leverage

Debt to equity

0.07
QNTM annual debt to equity ratio is 0.07

Interest coverage ratio

-312.35
QNTM annual interest coverage ratio is -312.35

Risk & Stability

Piotroski F-Score

-
QNTM piotroski f-score value is unknown

Altman Z-Score

-
QNTM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

EDSA logo
Edesa Biotech (EDSA)
IINN logo
Inspira Technologies Oxy BHN (IINN)
BCTX logo
BriaCell Therapeutics (BCTX)
IRIX logo
IRIDEX (IRIX)
EGRX logo
Eagle Pharmaceuticals (EGRX)
MODV logo
ModivCare (MODV)
VSee Health (VSEE)
LPCN logo
Lipocine (LPCN)
ELEV logo
Elevation Oncology (ELEV)
  • What is the ticker symbol for Quantum BioPharma?
  • Does Quantum BioPharma pay dividends?
  • What sector is Quantum BioPharma in?
  • What industry is Quantum BioPharma in?
  • What country is Quantum BioPharma based in?
  • Is Quantum BioPharma in the S&P 500?
  • Is Quantum BioPharma in the NASDAQ 100?
  • Is Quantum BioPharma in the Dow Jones?
  • When was Quantum BioPharma's last earnings report?
  • When does Quantum BioPharma report earnings?
  • Should I buy Quantum BioPharma stock now?

What is the ticker symbol for Quantum BioPharma?

The ticker symbol for Quantum BioPharma is NASDAQ:QNTM

Does Quantum BioPharma pay dividends?

No, Quantum BioPharma does not pay dividends

What sector is Quantum BioPharma in?

Quantum BioPharma is in the Healthcare sector

What industry is Quantum BioPharma in?

Quantum BioPharma is in the Drug Manufacturers - Specialty & Generic industry

What country is Quantum BioPharma based in?

Quantum BioPharma is headquartered in Canada

Is Quantum BioPharma in the S&P 500?

No, Quantum BioPharma is not included in the S&P 500 index

Is Quantum BioPharma in the NASDAQ 100?

No, Quantum BioPharma is not included in the NASDAQ 100 index

Is Quantum BioPharma in the Dow Jones?

No, Quantum BioPharma is not included in the Dow Jones index

When was Quantum BioPharma's last earnings report?

Quantum BioPharma's most recent earnings report was on May 14, 2024

When does Quantum BioPharma report earnings?

The next expected earnings date for Quantum BioPharma is May 14, 2025

Should I buy Quantum BioPharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page